Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Weight Management Protocol

TirzepatideComplete Dosing & Administration Guide

The dual-action powerhouse that targets both GIP and GLP-1 receptors, delivering the most dramatic weight loss results ever seen in a medication—averaging over 20% body weight reduction while also crushing blood sugar levels in people with diabetes.

Dose Range

2.5-15mg

Frequency

Once weekly

Route

Subcutaneous injection

Cycle Length

Ongoing/indefinite

Dosing

How much
do I take?

Starting Dose

2.5 mg

Frequency

Once weekly

Duration

4 weeks

This introductory dose helps your body adjust to the medication and minimizes GI side effects. Don't expect much weight loss yet—this phase is all about building tolerance. Think of it as your body's training wheels period.

Standard Dose

5-10 mg

Frequency

Once weekly

Duration

4+ weeks at each dose

After 4 weeks at 2.5mg, increase to 5mg. Stay here for at least 4 weeks, then move to 7.5mg, then 10mg. This gradual climb reduces side effects while ramping up the weight loss. Most people start seeing serious results at 5-10mg doses.

Advanced Dose

12.5-15 mg

Frequency

Once weekly

Duration

Ongoing/maintenance

The 15mg dose delivers maximum weight loss—averaging over 20% of body weight in trials. Continue increasing by 2.5mg every 4 weeks until reaching 15mg or your optimal maintenance dose. This is where the jaw-dropping results happen.

Timing

Best time to take

Pick any day of the week that works for you and stick with it. Many people choose a weekend day so they can rest if they experience mild nausea. The exact time of day doesn't matter much thanks to the long half-life—just be consistent.

With food?

Tirzepatide injections can be taken with or without food—it won't affect how the medication works. However, because it slows stomach emptying significantly, eating smaller meals will help you avoid nausea and discomfort. Avoid large, fatty meals.

If stacking

Tirzepatide is typically used as a standalone weight management therapy. If you have diabetes and take insulin or sulfonylureas, those doses will likely need to be reduced to prevent low blood sugar. Always coordinate with your healthcare provider before combining medications.

Adjusting Your Dose

Increase if

  • +You've tolerated the current dose for 4+ weeks without significant GI problems
  • +Weight loss has slowed or plateaued and you haven't reached the maximum dose
  • +Blood sugar targets aren't being met (for diabetes patients)
  • +Your healthcare provider recommends continuing the titration schedule

Decrease if

  • -Nausea, vomiting, or diarrhea are severe and don't improve after a few weeks
  • -You're unable to eat enough to maintain basic nutrition
  • -You experience signs of dehydration from persistent GI symptoms
  • -Side effects significantly impact your daily life and functioning

Signs of right dose

  • Steady weight loss of 1-2+ pounds per week
  • Feeling genuinely satisfied with smaller portions
  • Reduced food cravings and less thinking about food
  • Minimal or manageable GI side effects

Dosing Calculator

Calculate Your Exact Dose

1
2
3
4

Step 1: Peptide Weight

Find the weight printed on your peptide vial label

Look here!

The weight is on the label

Peptide vial
5mg

Select Weight

mg

Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)

Administration

How do I
use it?

Reconstitution

What you need

  • Pre-filled tirzepatide single-dose pen (Mounjaro or Zepbound)—no mixing required
  • Alcohol swabs for injection site cleaning
  • Sharps container for safe pen disposal
  • Calendar or reminder app for weekly dosing

Example

Tirzepatide comes in pre-filled, single-dose pens at specific strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg. Each pen contains exactly one dose—no calculations or dose selection needed. Simply use the entire pen contents for your weekly injection.

Each pen is designed for single use at its labeled dose. For example, a 5mg pen delivers exactly 5mg when fully administered. The pen mechanism ensures you receive the complete dose. Use one pen per week at your prescribed strength.

Injection

Route

Subcutaneous injection (into the fatty tissue just under the skin)—the pen makes it quick and virtually painless, and you can easily do it yourself at home

Best sites

  • Abdomen (stomach area)—at least 2 inches from belly button, most popular choice
  • Front of thighs—middle section of the upper leg
  • Back of upper arm—outer area, may need assistance from someone else

Technique

  • 1.Remove pen cap and check the medicine window—solution should be clear and colorless
  • 2.Clean your injection site with an alcohol swab and let it air dry completely
  • 3.Remove the base cap to reveal the needle (it's hidden until you're ready)
  • 4.Press the pen firmly against your skin at a 90-degree angle
  • 5.Press and hold the purple injection button until you hear two clicks
  • 6.Keep the pen pressed against your skin until the gray plunger is visible (about 5-10 seconds)
  • 7.Remove the pen and dispose of the entire pen in a sharps container—each pen is single-use
Full Injection Guide

Storage

Before reconstitution

Store new, unopened pens in the refrigerator at 36-46°F (2-8°C). Never freeze tirzepatide—freezing destroys the medication. Keep pens in the original carton to protect from light. If needed, unopened pens can be stored at room temperature (up to 86°F/30°C) for up to 21 days.

After reconstitution

Tirzepatide pens are single-use and do not require reconstitution. Once you use a pen, dispose of it properly in a sharps container. Never reuse pens or attempt to get multiple doses from one pen.

Signs of degradation

  • Solution appears cloudy, discolored, or contains particles (should be clear and colorless)
  • Pen has been frozen or exposed to temperatures above 86°F (30°C) for extended periods
  • Solution looks yellow, brown, or has changed from its original appearance
  • Pen is damaged, cracked, or the mechanism doesn't click properly

Sample Daily Schedule

Same day each week (e.g., every Sunday morning)

As prescribed (2.5mg to 15mg depending on titration phase) injection

Site: Rotate between abdomen, thigh, and arm weekly

Pick a day you'll consistently remember—many people choose weekends so they can rest if needed. The injection takes under a minute once you're comfortable with it. If you miss a dose and it's been less than 4 days, take it as soon as you remember. If more than 4 days have passed, skip it and take your next dose on the regular day.

Safety

Is it
safe?

Safety Profile

Tirzepatide has been extensively studied in the SURPASS (diabetes) and SURMOUNT (obesity) trial programs, involving thousands of participants over multiple years. The FDA approved it after thorough safety review. While GI side effects are common (especially during dose increases), they're typically mild to moderate and improve over time. Serious adverse events are rare. The SURPASS-CVOT trial is ongoing to evaluate long-term cardiovascular outcomes.

Safety data comes from multiple Phase 3 trials with follow-up extending beyond 72 weeks. The overall safety profile is similar to GLP-1-only medications like semaglutide, with GI symptoms being the most frequent issues. The thyroid tumor risk seen in rodents has not been confirmed in humans, but remains a theoretical concern requiring ongoing monitoring.

Common Side Effects

Experienced by some users

Nausea

The most frequently reported side effect, affecting about 25-30% of users. It's usually worst during the first few weeks and when increasing doses, then typically fades as your body adjusts.

Management: Eat smaller, more frequent meals. Avoid greasy, fried, or heavy foods. Stay upright after eating. Ginger tea or ginger candies can help. The slow dose escalation protocol is designed to minimize this—don't rush the titration.

Diarrhea

Affects about 15-20% of users, particularly during dose increases. Your digestive system is adjusting to significantly slower stomach emptying and changed gut signaling.

Management: Stay well hydrated with water and electrolytes. Avoid caffeine and alcohol which can worsen symptoms. Consider a probiotic. Over-the-counter anti-diarrheals can help if needed. Usually improves within a few weeks.

Decreased Appetite

This is actually how tirzepatide works—it's the intended effect, not a side effect. You'll genuinely feel less hungry and more satisfied with smaller amounts of food.

Management: While reduced appetite is the goal, don't skip meals entirely. Focus on nutrient-dense, protein-rich foods at each meal. Aim for at least 60-80g of protein daily to preserve muscle mass. Set reminders to eat if you're forgetting meals.

Vomiting

About 10-15% of users experience vomiting, especially during the titration phase. Like nausea, it's typically temporary and improves as your body acclimates.

Management: If vomiting is persistent, contact your healthcare provider—they may recommend staying at your current dose longer before increasing. Ensure adequate hydration. Anti-nausea medications may be prescribed if needed.

Less Common

  • Gallbladder Problems
  • Hair Thinning (Telogen Effluvium)

These typically resolve with continued use or dose adjustment.

Stop and Seek Help If

  • ×Severe or persistent GI symptoms that prevent adequate nutrition despite dose adjustments and supportive care
  • ×Signs of pancreatitis—severe abdominal pain radiating to the back requiring emergency evaluation
  • ×Allergic reaction—rash, hives, itching, facial swelling, or difficulty breathing
  • ×Signs of thyroid problems—neck lump, persistent hoarseness, difficulty swallowing
  • ×Pregnancy or planning to become pregnant (stop at least 1 month before attempting conception)
  • ×Severe kidney problems or persistent dehydration from GI symptoms
  • ×Your healthcare provider recommends discontinuation for any reason

Tirzepatide is a prescription medication that should only be started, adjusted, or stopped under medical supervision. This information is for education only and does not replace professional medical advice. While stopping tirzepatide abruptly is generally safe, discuss any changes with your healthcare provider. Weight regain is common after discontinuation.

Interactions

With other peptides

  • !Never combine GLP-1 medications—they work through overlapping mechanisms. Combining would dramatically increase side effects without additional benefit.
  • No direct interaction data exists. BPC-157 is sometimes used for gut healing which could theoretically help with GI side effects, but this is speculative and unstudied.
  • Limited interaction data available. Both can affect glucose metabolism, so combining should only be done under close medical supervision.

With medications

  • !Insulin - Tirzepatide dramatically enhances insulin's blood sugar-lowering effect. Insulin doses typically need reduction of 20-50% or more when starting tirzepatide to prevent dangerous hypoglycemia. Close monitoring essential.
  • !Sulfonylureas (glipizide, glyburide, glimepiride) - High hypoglycemia risk when combined. Sulfonylurea doses usually need significant reduction. Monitor blood sugar frequently and watch for symptoms of low blood sugar.
  • Oral Contraceptives - Tirzepatide's effect on gastric emptying may alter absorption of oral medications. Consider using alternative or backup contraception, especially during dose changes.
  • Warfarin - May affect warfarin absorption and metabolism. Increased INR monitoring recommended when starting tirzepatide or changing doses.
  • Acetaminophen and other oral medications - Significantly delayed gastric emptying may slow absorption of oral medications. Consider timing and discuss with your pharmacist.

With supplements

  • Vitamin B12 - Long-term use of incretin medications may reduce B12 absorption. Consider B12 supplementation, especially if you've been on tirzepatide for over a year.
  • Fiber Supplements - Can help manage constipation but start slowly—too much fiber too fast can worsen GI symptoms. Psyllium husk is a gentle option.
  • Protein Supplements - Highly recommended to preserve muscle mass during rapid weight loss. Aim for 1g protein per pound of goal body weight, or at least 60-80g daily.
  • Electrolyte Supplements - Helpful if experiencing diarrhea or vomiting to prevent dehydration and electrolyte imbalances.

Want the Full Picture?

View the complete Tirzepatide research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ.

View Full Tirzepatide Profile

Medical Disclaimer

Tirzepatide is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: 2/8/2026

Tirzepatide Protocol — Complete Dosing & Administration Guide | Peptide Initiative